
The ESC heard the latest on the Endeavor stent, which elutes the sirolimus analogue ABT-578. Jean Fajadet from Toulouse told Audio Medica about the findings from ENDEAVOR II study of around 1200 patients.
Click here for all the interviews from ESC 2005

Post a comment